Human Vaccines Project and Seqirus partner to advance universal flu vaccine research

(Human Vaccines Project) The Human Vaccines Project, a nonprofit public-private partnership focused on decoding the immune system to improve human health, announced today that Seqirus, a global leader in the prevention of influenza, is joining the Project's Universal Influenza Vaccine Initiative (UIVI). Seqirus, owned by CSL Limited, has been on the front line of influenza vaccine development and pandemic preparedness for more than a century, pioneering new technologies for rapidly producing influenza vaccines.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news